Alginate Nicotine Composition for Stable Oral and Nasal Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing compositions for delivering biologically active agents, particularly nicotine, to the oral or nasal cavity face challenges in maintaining stability during manufacturing and storage, especially in high water content systems, while ensuring a controlled release profile and user compliance.
Innovation Solution
Compositions comprising alginate as a matrix forming agent, ammonium citrate as an antioxidant, and a filling agent, which stabilize nicotine through complex binding and control its release, maintaining stability and compliance with mucosa.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If alginate matrix is used as matrix forming agent, then release characteristics and stabilization of active agents are improved, but additional antioxidant protection is still needed for very liable active agents during long term storage
Solution Approach 1:
The patent combines alginate matrix with additional antioxidants (vitamin C, vitamin E, BHT) to create a composite stabilization system. The alginate provides baseline protection through its oxygen barrier properties and pH control, while the added antioxidants provide enhanced protection against oxidative degradation during long term storage, especially in high water content systems where degradation is more rapid.
2Ease of operation
If high water content is used in composition, then compliance with mucosa is improved, but degradation of liable active agents increases during storage
Solution Approach 1:
The patent maintains high water content (40-70% w/w) to ensure mucosal compliance and user comfort, but compensates for the increased degradation risk by adjusting other parameters: adding multiple antioxidants, controlling pH within 6.0-8.0 using alginate buffer capacity, and selecting packaging that minimizes oxygen exposure. This multi-parameter adjustment allows high water content formulations to remain stable during storage.
3Stability of the object's composition
If antioxidant is added to stabilize nicotine, then storage stability is improved, but complexity of composition increases
Solution Approach 1:
The patent uses alginate as an intermediary substance that provides pH buffering (maintaining 6.0-8.0) and oxygen barrier properties, reducing the burden on added antioxidants. This intermediary role of alginate allows the use of smaller amounts of antioxidants compared to systems without alginate, thereby stabilizing nicotine while limiting complexity increase.
4Reliability
If multiple antioxidants are combined with alginate, then stabilization effectiveness is improved, but manufacturing complexity increases
Solution Approach 1:
The patent incorporates antioxidants during the granulation or mixing stage before final product formation, allowing them to be pre-distributed throughout the alginate matrix. This preliminary incorporation ensures uniform protection throughout the product and simplifies manufacturing compared to post-processing antioxidant addition, as it integrates stabilization into the existing formulation workflow.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compositions provide enhanced stability and controlled release of nicotine, mimicking conventional tobacco products, with improved shelf life and user satisfaction.
Implementation Method 1
WO 2010/0104464 indicates that the alginate matrix may form an oxygen barrier
Implementation Method 2
a complex binding antioxidant... comprising at least one ammonium citrate or a salt thereof
Data Source
AI summary
The specification discloses compositions for use in the oral or nasal cavity comprising a biologically active agent, a matrix forming agent comprising alginate and suitable salts thereof, a filling agent and at least one antioxidant that is an effective complex binder. The compositions can further comprise additional excipients such as preservatives, taste or flavour enhancers, pH adjusters, plasticizers and sweeteners. The specification also discloses methods of producing the compositions.